Dr. Fakhery Bani Issa, has Over 27 years of experience in healthcare, Over 24 years of experience in implementing quality in healthcare and over 23 years’ experience in nursing Director and teaching. He completed his Bachelors (B.Sc.) In Nursing, Clinical Instructor Diploma in 1995, Certified HQPC from HCAC & ISQA, Certified Hospital Surveyor from HCAC & ISQA 2013, and Certified Primary Health Care Surveyor from HCAC & ISQA 2013, Certified Laboratory, Dental clinic and Ambulatory clinic Surveyor from HCAC & ISQA 2017, Certified Quality Consultant from HCAC & ISQA 2018, Certified Highness Princess Mona Al Hussein of excellence in management and leadership. He Serve as, RN. In Abu Obideh Hospital 1990 – 1991, RN In Royal Medical Services King Hussain Hospital 12/1990 – 4/1992,RN in Princess Basma Hospital 8/1992 – 4/1994,Clinical Instructor College 1994 – 1995, NURSING DIRECTOR PRINCESS RAYAH HOSPITAL FROM 1995 UNTIL NOW, Member Of Decentralization Project Collaborated With (PHR) (USAIDs).(Quality improvement program) in 1999 to 2002, Member in King Abdullah Prize Committee for Preferred Performance and Transparency in 2003, Coordinator Princess Rayah Hospital with Ministry Of Health in King Abdullah Prize for Preferred Performance and Transparency. In 2004, Member of Answer Question of King Abdullah Prize for Preferred Performance and Transparency Committee in Ministry Of Health. In 2004,Member Of Job Description Prepared Committee In Princess Rayah Hospital With Cooperation (PHR) Project (USAIDs).(quality improvement program)from 2002 to 2003, Co-ordinate of Quality Improvement Committee in Princess Rayah Hospital. From 2004 until now, Certification from Accreditation Project in Training of Accreditation and quality.

Health Care, Critical Care, Patient Saftey

Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran University School of Medicine with honor. He studied in neurosurgery ward and graduated with A score with a thesis on Meningioma Brain Tumor during 6 years. With continuing his practice with special consideration on psychosomatic disorders, He completed many post-graduate courses on health psychology, addiction medicine, sexual disorders therapy successfully. He passed many post graduate courses in Neuro, approved by Medical sciences university. As well, He have been passed post graduate courses on Nutrition, Gastroenterology and hepatology, Obesity treatment and diabetes approved by Tehran University of Medical sciences. He successfully passed more than 10 programs with certificates and membership in the Iranian Association of Gastroenterology and Hepatology. Having honor of working as associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). This strong study background enabled me to successfully earn certificates on 3 programs: Updates of skin and treatment from Tehran university 2015 and course on skin care updates from Iranian society of practitioners on 2016, and during 2 years, I had passed Beauty and Skin care courses in South Korea and certified from Sunghuwan co Ltd for using and working of beauty technology, RF and IPL. He is director of fatty liver and related metabolic disorders study among Iranian families since 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Iran Hepatitis Network. He is a reviewer and associate editor of Hepatitis Monthly Journal and reviewer of journal of Clinical and Translational Hepatology. He is editorial board member of the International Journal of Psychology and Neurosciences. He is a certified graduate, verified reviewer and certified mentor of Publons academy in the field of Clinical Medicine and Hepatology. He published reviews for articles on Brain Tumor Immunotherapy, CNS Tumor Guideline and Alzheimer's disease in Elsevier and Kudos. My review on Alzheimer's disease article with specific DOI, was published in the American Physiological Society. He has been invited by editor in chief of American Journal of Translational Medicine, to participate at International Conference of Translational Medicine, in Hawaii. My article entitled "Trigeminal Neuralgia caused by Brain Meningioma" has been accepted for oral presentation in world neurology and Neurodisorders Conference, Tokyo as keynote speaker. My article in the field of neuroscience about 'Recurrent Meningioma', etiologies and clinical aspects and tumor cellular pathology has been accepted for oral, poster presentation in World CNS Conference, France 2018.

Fatty liver and Hyperlipidemia, Diabetes and Nutrition, Clinical Medicine and Hepatology, Brain Tumor

Mr. Nizar is an astute physical therapist and sagacious rehab science researcher currently working as Senior Lecturer in Physiotherapy, Faculty of Medicine and Health Sciences, at University Tunku Abdul Rahman, Malaysia. His commitment to teaching excellence has earned him accolades. His research interest spans a variety of topics in obesity, physical activity, sedentary behavior and diabetic peripheral neuropathy. He presented his research findings at international conferences, published articles in prolific journals, and was awarded with scholarships and research grants. He serves as associate editor and reviewer for high end academic journals. Mr. Nizar served as Head of Department of Physiotherapy at Mahatma Gandhi University, Kerala, India. He has been invited as keynote speaker at international health care conferences. He writes health care articles for periodicals and national dailies.

Life-Sciences & Healthcare, Diabetes, Cognitive Fitness

Dr. Ian Martins is a Reveiwer for Open Acess Pub and various other international journals. Appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017), Research and Reviews: Neuroscience (2016-2017)/Journal of Diabetes and Clinical Studies and Editor for various journals. He is a BIT Member (BIT Congress. Inc) with an H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). He is now a Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places publication Stats RG score higher than 96% of the international SCIENTISTS. Prestigious Recognition of Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition), Endocrinology and Metabolism.Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition).

Diabetes & Endocrinology

Yanfei (Jacob) Qi is establishing his scientific reputation in lipid research. He is currently Head of Diabetes Lipid Metabolism Laboratory at Centenary Institute, The University of Sydney (USYD), Australia. His current research focuses on the lipid metabolism and signaling in type 2 diabetes (T2D). Jacob commenced his research career with pharmacological studies of anti-diabetic medicines at USYD, and then continued his research as foreign co-researcher at Kyoto University, Japan. Jacob obtained his PhD at Sydney Medical School, USYD. His PhD study focused on sphingolipid signaling and lipotoxicity in T2D and NAFLD. More recently, he was research fellow at The University of NSW, Australia, where he developed research expertise in phospholipid metabolism, intracellular lipid transport and lipid droplet biology. Jacob published a number of well-cited first-author papers in the past 5 years. His research output has been increasing as reflected in the number of publication and citation per annum.

Dysregulated lipid metabolism is a well-known risk factor in the development of type 2 diabetes. Ectopic lipid accumulation in the liver causes insulin resistance, while lipid overloading of pancreatic islets impairs insulin secretion due to lipotoxic stress. Our research focuses on multiple aspects of lipid metabolism: how sphingolipids and phospholipids regulate hepatic insulin resistance both in vivo and in vitro; how sphingolipids determine pancreatic beta-cell viability; how neutral lipids are stored and mobilised in adipocytes; and how phospholipids are transported within cells. In addition to lipid studies in the pathogenesis of type 2 diabetes, we also aim to identify lipid biomarkers for diabetes at early diagnosis. The majority of pre-diabetic subjects proceed to type 2 diabetes, however, prediabetes is usually unrecognised, which constitutes a major public health concern. Thus, identification of high-risk individuals via a biomarker is urgently needed. We will utilise the plasma sample bank from a cohort with over 6,000 subjects to screen the lipid species that is closely correlated to insulin resistance and prediabetes.

Presently Dr. MOHD. AKHTAR working as Senior Assistant Professor in the Department of Pharmacology, School of Pharmaceutical Education and Research (Formerly: Faculty of Pharmacy ranked Ist in NIRF Ranking) Jamia Hamdard (Hamdard University) Mahruali Badarpur Road, Sangam Vihar New Delhi 110 062. He did his B.Pharm, M.Pharm Ph.D (Pharmacology) from Jamia Hamdard. Before joining Hamdard, he worked as clinical Pharmacist in Saudi Arabia for 2 and half years and as lecturer in HNB Garhwal University. Has more than 17 years of teaching and research experience. He supervised more than 37 M. Pharm Pharmacology; Pharmacy Practice and M.D students also supervised 7 Ph.D students. His areas of Research include CNS, CVS, Endocrine, drug-drug interaction studies, Pharmacovigilance studies. He has more than 90 research papers in national and international journals of repute. He also received projects like fast track project for young scientist from DST, AICTE, CCRUM. He received scientist of the year 2008 award from NESA, Recipient of 2nd Academic Brilliance Awards 14 for Excellence in research presented by Education Expo 2014. He has presented papers in so many symposiums, conferences and workshops. He is life member of IPS, APTI, IPGA, IHPA Society of Pharmacovigilance and NESA.

Diabetes & Endocrinology

An experienced and caring clinician with extensive experience in caring for patients in government and private set ups. Experienced in modern hospital care set up in Singapore. A brilliant academician with gold medals / honours in almost every subject during medical training, best student of the year 1987, University of Calcutta topper in MBBS First part 1987, followed by Post doctoral and Royal College of UK degrees. Excellent speaker regular at API, ESI, DAI conferences. Extensive experience in medical teaching at under and post graduate levels.

Diabetes & Endocrinology

Joe Michel Chehade is a Professor of Medicine University of Florida College of Medicine, Jacksonville, Florida.He was the director of Saint Francis Medical Center, Cape Girardeau, MO. May 2000- July 2007 (ADA Accredited Program).South East Missouri Hospital, Cape Girardeau, MO. May 2000-July 2007.Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty, 1999-2009, Recertification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism Subspecialty, 2009-2019.He has published 2 book Book Chapters: 1.Chehade JM, Mooradian AD. Drug Therapy: Current & Emerging Therapy in Type 2 Diabetes in Diabetes in Old Age. 2001 (Second Edition) 199-214; Wiley Publication, Sinclair JA, Finucane P. 2.Chehade JM, Mooradian AD. Drug Therapy: Current & Emerging Agents for Hyperglycaemia in Diabetes in Old Age. 2009 (Third Edition) 245-264; Wiley Publication, Sinclair JA, Finucane P. He has published 30+ articles.

ongoing research 1. Chehade JM, Haas MJ. Effects of GLP-1 & Exenatide on HDL cholesterol. Amylin Pharmaceuticals, Inc. (21975$). 2. Chehade JM, Mooradian AD. Age-related changes in thyroid hormone action in humans. Dean’s Fund Faculty Research Grant. (9083$).

Prof Muller focuses his research on the potential role of phenolic compounds in the prevention and treatment of metabolic conditions such as insulin resistance, dysbiosis, obesity and type 2 diabetes. He is also involved with a proteomics study to identify early markers for type 2 diabetes. These markers are currently being tested in human subjects. He has 2 International patents (the USA and Europe) for the prevention of diabetes and has authored and co-authored 81 peer-reviewed articles and two book chapters.

Metabolic disease (pathophysiology, prevention, and treatment), phytotherapeutics and early detection of type 2 diabetes.

Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 2000-2005. He obtained a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He obtained a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: (i) Fellow of the Canadian Cardiovascular Society (FCCS) in 2016, (ii) Fellow of the American Heart Association (FAHA) in 2011; (iii) Fellow of the International College of Angiology (FICA) in 2007; (iv) Young Investigator Award by International College of Angiology (2007); (v) Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics-Division for Drug Discovery, Development & Regulatory Affairs (2005); (vi) Young Investigator Award by the Society of Experimental Biology and Medicine (2005); (vii) Caroline tum Suden/Frances A Hellebrandt Professional Opportunity Award for Meritorious Research by the American Physiological Society (2005); and (viii) Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). Top 5% of cited authors in journals of Biology and Biochemistry in 2011, by Thomson-Reuters. Currently, Dr. Ndisang is an Editor for Frontiers in Bioscience (impact factor 3.8) and Executive Guest Editor for Current Medicinal Chemistry (impact factor 3.7) He has published more than 64-full length manuscripts in peer-reviewed journals and more than 80 abstracts. Dr. Ndisang has served as external PhD examiner for several universities in Canada, has given more than 30-invited talks, and has also served as peer-reviewer for several reputed journals and granting agencies in United States, United Kingdom, Canada, New Zealand and Poland.

His research is mainly focused on investigating the role of the heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity.

Born in Germany in 1972. He completed his specialist education at Ege University. During his professional life, she worked as a psychiatric specialist in a general medical hospital, as an associate professor of psychiatry in the second largest mental health hospital in the Turkey. Since 2014, as a professor of psychiatry, she has taught at Üsküdar University and has been working with bipolar disorder in NPIstanbul Brain Hospital. Another area of interest is psychoanalytic psychotherapies.

Bipolar Disorder

I have been a consultant in Diabetes and Endocrinology for the last 13 years and have published many papers. I am a champion of expert patient programme and have taught patients to take control of their disease. My efforts in this area were recognised by Dept of Health. I am an examiner of post graduate exam in medicine. I have been divisional director for Dept of Medicine for last 6 years

All diabetes related diseases and diabetic foot. Special interest in thyroid and reproductive medicine. I also see patients with general medical problems which do not fall in specialist category Medical secretaries

Gerald C. Hsu received an honorable Ph.D. in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010-2013, then conducted research during 2014-2018. His approach is math-physics and quantitative medicine based on mathematics, physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

preventive medicine